LEADER 02046nam  2200457   450 
001 9910702660903321
005 20141002132839.0
035   $a(CKB)5470000002429579
035   $a(OCoLC)891964736
035   $a(EXLCZ)995470000002429579
100   $a20141002d2014      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aDrug shortages, threat to public health persists, despite actions to help maintain product availability : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /$fstatement of Marcia Crosse
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2014.
215   $a1 online resource (9 pages) $ccolor illustrations
225 1 $aTestimony ;$vGAO-14-339T
300   $aTitle from title screen (viewed Sept. 16, 2014).
300   $a"For release ... February 10, 2014."
320   $aIncludes bibliographical references.
517   $aDrug shortages, threat to public health persists, despite actions to help maintain product availability 
606   $aDrugs$xSupply and demand$zUnited States
606   $aDrug accessibility$zUnited States
606   $aDrugs$xPrices$zUnited States
606   $aPharmaceutical industry$zUnited States
615  0$aDrugs$xSupply and demand
615  0$aDrug accessibility
615  0$aDrugs$xPrices
615  0$aPharmaceutical industry
700   $aCrosse$b Marcia$01380679
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Health,
712 02$aUnited States.$bGovernment Accountability Office,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910702660903321
996   $aDrug shortages, threat to public health persists, despite actions to help maintain product availability : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives$93536516
997   $aUNINA